# A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus

> **NCT01514838** · PHASE3 · TERMINATED · sponsor: **Astellas Pharma Inc** · enrollment: 46 (actual)

## Conditions studied

- Type II Diabetes Mellitus

## Interventions

- **DRUG:** ASP1941
- **DRUG:** acarbose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01514838
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-04-23
- **Primary completion:** 2012-10-19
- **Final completion:** 2012-10-19
- **Target enrollment:** 46 (ACTUAL)
- **Why stopped:** Discontinued due to company's strategic reason
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01514838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01514838, "A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01514838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*